Madrigal Pharmaceuticals, Inc. (MDGL)
529.84
+6.37
(+1.22%)
USD |
NASDAQ |
Apr 01, 16:00
527.66
-2.18
(-0.41%)
After-Hours: 20:00
Madrigal Pharmaceuticals Research and Development Expense (TTM) : 387.02M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 771.09M |
| Pfizer Inc. | 10.25B |
| Eli Lilly & Co. | 13.34B |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| PTC Therapeutics, Inc. | 455.25M |